Old Web
English
Sign In
Acemap
>
authorDetail
>
Dragana Jankovic
Dragana Jankovic
Novartis
in patient
Medicine
Oncology
Internal medicine
advanced breast
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Long-term (LT) disease control in patients (pts) with hormone receptor-positive (HR+), PIK3CA-altered advanced breast cancer (ABC) treated with alpelisib (ALP) + fulvestrant (FUL).
2021
Journal of Clinical Oncology
Dejan Juric
Fabrice Andre
Udaiveer Panwar
Filip Janku
Yen-Shen Lu
Howard A. Burris
Josefina Cruz Jurado
Zsuzsanna Papai
Salomon M. Stemmer
Josep Tabernero
Johan Ahlgren
Marianne Leheurteur
I. Lorenzo
Dragana Jankovic
Cornelia Quadt
Huilin Hu
Xueying Chen
Hope S. Rugo
Show All
Source
Cite
Save
Citations (0)
Phase II study of the anti-TGF-β monoclonal antibody (mAb) NIS793 with and without the PD-1 inhibitor spartalizumab in combination with nab-paclitaxel/gemcitabine (NG) versus NG alone in patients (pts) with first-line metastatic pancreatic ductal adenocarcinoma (mPDAC).
2021
Journal of Clinical Oncology
Peter Grell
Chia-Chi Lin
Michele Milella
Cheng Ean Chee
Shivan Sivakumar
Katriina Peltola
Geraldine Bostel
Dragana Jankovic
Maria-Athina Altzerinakou
Claire Fabre
Armando Santoro
Show All
Source
Cite
Save
Citations (0)
1